phenytoin has been researched along with clindamycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rane, A; Wilson, JT | 1 |
| Góngora-Rivera, F; Moreno-Andrade, T; Ramírez-Crescencio, MA; Soto-Hernández, JL | 1 |
| Hooge, J; Maguire, J; Pfeffer, G; Prout, A | 1 |
1 review(s) available for phenytoin and clindamycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for phenytoin and clindamycin
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Clinical pharmacokinetics in infants and children.
Topics: Aging; Body Water; Carbamazepine; Child; Child, Preschool; Clindamycin; Dextropropoxyphene; Diazoxide; Dicloxacillin; Digoxin; Ethosuximide; Humans; Infant; Infant, Newborn; Kidney; Kinetics; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Propranolol; Sulfonamides; Tetracycline; Theophylline | 1976 |
Nocardia abscess during treatment of brain toxoplasmosis in a patient with aids, utility of proton MR spectroscopy and diffusion-weighted imaging in diagnosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Retroviral Agents; Anticonvulsants; Antiprotozoal Agents; Brain Abscess; Clindamycin; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Humans; Magnetic Resonance Spectroscopy; Male; Nocardia asteroides; Nocardia Infections; Phenytoin; Protons; Pyrimethamine; Toxoplasmosis, Cerebral | 2006 |
Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antiretroviral Therapy, Highly Active; Biopsy; CD8-Positive T-Lymphocytes; Clindamycin; Frontal Lobe; Humans; Immune Reconstitution Inflammatory Syndrome; Immunoglobulin G; Lymphocyte Activation; Magnetic Resonance Imaging; Male; Phenytoin; Pyrimethamine; Seizures; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome | 2009 |